Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Cardiology
•
Cardiovascular Imaging
For a patient with prior bypass graft stenting and severe native vessel disease, would you recommend myocardial perfusion imaging or coronary CTA if there is concern about graft patency?
Related Questions
When would you consider using cardiac MRI over nuclear imaging for functional assessment of ischemic heart disease, since it is class IIa indication in the US but otherwise class I in Europe?
What are your outpatient surveillance strategies (biomarkers, imaging, symptoms) to monitor response to treatment for ATTR amyloidosis with cardiac involvement?
What clinical or echocardiographic parameters do you use to determine the optimal timing for an aortic valve intervention in patients with asymptomatic severe aortic stenosis?
When do you favor using cardiac CT compared to TEE for outpatient surveillance in the immediate post-Watchman period?
What are your top takeaways from ACC 2024?
How reliable is an exercise stress echo in the diagnosis of exercise-induced heart failure with preserved ejection fraction?
Would you favor functional or anatomical assessment for CAD in a patient with intermediate CV risk factors with equivocal or nondiagnostic exercise treadmill testing and normal renal function?
What are your top takeaways from AHA 2023?
What is the best way to categorize aortic stenosis in normal LV function with normal LV size, when the peak velocity and mean pressure gradient are in moderate range but AVA shows severe?
What is the preferred imaging modality to evaluate subaortic membranes in patients with aortic valve disease?
